Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[This raises the question as to whether there is a subset of patients with skin cancer or AK lesions that are highly/more susceptible to local reactions caused by cyclo-oxygenase-2 (COX-2) inhibitors and peroxisome proliferator-activated receptor (PPAR) agonists?]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP807579.RAQr0-tpOmHkvFYU73L6NLKbMER9XJnr41QiqRAy7rPiM130_assertion description "[This raises the question as to whether there is a subset of patients with skin cancer or AK lesions that are highly/more susceptible to local reactions caused by cyclo-oxygenase-2 (COX-2) inhibitors and peroxisome proliferator-activated receptor (PPAR) agonists?]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP807579.RAQr0-tpOmHkvFYU73L6NLKbMER9XJnr41QiqRAy7rPiM130_provenance.
• NP573840.RAciqo-t0nJuCqGMGQJSMq34JvgpoYlggZOoDoyhlyPvM130_assertion description "[This raises the question as to whether there is a subset of patients with skin cancer or AK lesions that are highly/more susceptible to local reactions caused by cyclo-oxygenase-2 (COX-2) inhibitors and peroxisome proliferator-activated receptor (PPAR) agonists?]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP573840.RAciqo-t0nJuCqGMGQJSMq34JvgpoYlggZOoDoyhlyPvM130_provenance.
• NP656898.RAVqbc9pCy8PrPTB_rpSGlDnXEgsVVlsyCDhn9WOYHpSE130_assertion description "[This raises the question as to whether there is a subset of patients with skin cancer or AK lesions that are highly/more susceptible to local reactions caused by cyclo-oxygenase-2 (COX-2) inhibitors and peroxisome proliferator-activated receptor (PPAR) agonists?]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP656898.RAVqbc9pCy8PrPTB_rpSGlDnXEgsVVlsyCDhn9WOYHpSE130_provenance.
• assertion description "[This raises the question as to whether there is a subset of patients with skin cancer or AK lesions that are highly/more susceptible to local reactions caused by cyclo-oxygenase-2 (COX-2) inhibitors and peroxisome proliferator-activated receptor (PPAR) agonists?]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[This raises the question as to whether there is a subset of patients with skin cancer or AK lesions that are highly/more susceptible to local reactions caused by cyclo-oxygenase-2 (COX-2) inhibitors and peroxisome proliferator-activated receptor (PPAR) agonists?]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP768005.RAL8eNbyq27UGUPIdwNnzGzf_DvrC7hhNbVzp5OlBznv4130_assertion description "[This raises the question as to whether there is a subset of patients with skin cancer or AK lesions that are highly/more susceptible to local reactions caused by cyclo-oxygenase-2 (COX-2) inhibitors and peroxisome proliferator-activated receptor (PPAR) agonists?]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP768005.RAL8eNbyq27UGUPIdwNnzGzf_DvrC7hhNbVzp5OlBznv4130_provenance.
• NP573002.RAhOInquRvp36z_JMeMqYSDe57HFIq1yvTC_30CuZocQo130_assertion description "[This raises the question as to whether there is a subset of patients with skin cancer or AK lesions that are highly/more susceptible to local reactions caused by cyclo-oxygenase-2 (COX-2) inhibitors and peroxisome proliferator-activated receptor (PPAR) agonists?]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP573002.RAhOInquRvp36z_JMeMqYSDe57HFIq1yvTC_30CuZocQo130_provenance.
• NP658293.RAMjABWq0X3BA5mYvj-GuhoaMCbsXjGDxvZKAEVtS_aDI130_assertion description "[This raises the question as to whether there is a subset of patients with skin cancer or AK lesions that are highly/more susceptible to local reactions caused by cyclo-oxygenase-2 (COX-2) inhibitors and peroxisome proliferator-activated receptor (PPAR) agonists?]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP658293.RAMjABWq0X3BA5mYvj-GuhoaMCbsXjGDxvZKAEVtS_aDI130_provenance.
• NP608978.RA5AhtI4QXujm3DZsjuj7jYmwbdgOXjc3qUuvTDp6GcsY130_assertion description "[This raises the question as to whether there is a subset of patients with skin cancer or AK lesions that are highly/more susceptible to local reactions caused by cyclo-oxygenase-2 (COX-2) inhibitors and peroxisome proliferator-activated receptor (PPAR) agonists?]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP608978.RA5AhtI4QXujm3DZsjuj7jYmwbdgOXjc3qUuvTDp6GcsY130_provenance.
• NP608979.RA0NVOU7i_oe2o-Rq3tMdVnB0MjfOncmxdKox4NpQoAXs130_assertion description "[This raises the question as to whether there is a subset of patients with skin cancer or AK lesions that are highly/more susceptible to local reactions caused by cyclo-oxygenase-2 (COX-2) inhibitors and peroxisome proliferator-activated receptor (PPAR) agonists?]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP608979.RA0NVOU7i_oe2o-Rq3tMdVnB0MjfOncmxdKox4NpQoAXs130_provenance.